Introduction {#sec1-1}
============

Severe chronic mitral regurgitation (MR) is characterized by excessive volume load, leading to serial cardiac adaptations \[[@ref1]\].Among which, left atrial (LA) dilatation arises early, maintaining a balanced LA pressure while prohibiting pulmonary congestion. However, the rapidity of this compensatory process *per se* forecasts dire outcomes. LA volume index (LAVi), signifying LA remodeling, has been well acknowledged as a prognostic indicator with respect to atrial fibrillation (AF), stroke, and congestive heart failure \[[@ref2][@ref3][@ref4]\]. Similarly, in primary MR (characterized by pathology involving mitral leaflets, chordae tendineae, papillary muscle, and annulus), LAVi is a harbinger of increased mortality and more cardiac events, including subsequent occurrence of AF \[[@ref2][@ref5][@ref6][@ref7]\]. As a matter of fact, identifying patients with severe primary MR who are at risk of accelerated LA remodeling is pivotal in guiding patient-tailored therapeutic strategy to improve their survival and restore their quality of life.

By contrast, the association between severe primary MR and impaired LA deformation assessed by two-dimensional (2D) speckle-tracking echocardiography (STE) has been demonstrated \[[@ref8][@ref9]\]. Changes of LA deformation mechanics, reflecting LA ultrastructural change, may occur before changes in LA dimension \[[@ref10]\]. LA deformation indexes have been utilized in the prediction of functional capacity, future cardiac events, as well as postoperative survival in severe primary MR, suggesting their value in clinical practice \[[@ref11][@ref12][@ref13]\]. It is of interest whether accelerated LA remodeling and LA deformation deterioration are closely interwoven.

Using 2D STE, phasic LA deformation can be evaluated, including the reservoir, conduit, and contractile functions. Notably, the prognostic implication of a reduced LA reservoir function, represented by decreased LA reservoir strain (LA~ε~R) and strain rate (LASR~R~), has been recognized, assuring its value and importance in chronic MR \[[@ref12][@ref13][@ref14]\]. During ventricular systole, LA strain (ɛ) and strain rate (SR) reflect LA expansibility and stiffness. Our previous studies found that deformation in the reservoir phase is associated with functional capacity and prognosis in severe chronic primary MR, especially for Carpentier II classification (mitral valve prolapse or flail) \[[@ref12][@ref13]\]. However, determinants of reservoir deformation have not been elucidated in this group. Hence, the current study aims to explore the (1) determinants of a poor LA reservoir function, (2) determinants of accelerated LA remodeling, and (3) interconnection between LA remodeling and LA reservoir mechanics in patients with chronic severe Carpentier II MR.

Methods {#sec1-2}
=======

Study population {#sec2-1}
----------------

[Figure 1](#F1){ref-type="fig"} shows the study flow diagram of this prospective observational cohort study. Patients with chronic severe primary MR undergoing echocardiography in the outpatient clinic were screened between December 2010 and August 2013. We did not enroll patients with: (1) left ventricular ejection fraction (LVEF) \< 60%; (2) New York Heart Association (NYHA) functional classification III or IV; (3) ischemic MR; (4) infiltrative cardiomyopathy; (5) coexistent aortic valve disease and mitral stenosis ≥ mild degree; (6) prior open heart surgery; and (7) congenital heart disease. Eighteen of 177 patients with chronic severe Carpentier II MR were excluded because of an anticipated mitral valve surgery at the time of the index echocardiography or inadequate image acquisition.

![Study flow diagram--dpatients included and excluded from the study. EF = ejection fraction; LV = left ventricular; LVEF = left ventricular ejection fraction; MR = mitral regurgitation; MV = mitral valve; NYHA = New York Heart Association functional classification;](JMU-25-16-g001){#F1}

Severe MR was diagnosed using a multiparametric approach via transthoracic echocardiography, including evaluation of the vena contracta width, effective regurgitant orifice area, regurgitant volume, and presence of systolic pulmonary venous flow reversal aligned with the European Association of Echocardiography criteria \[[@ref15]\]. Patients were followed up (interval ≤3 months), by their original cardiovascular specialists, in the clinic where symptoms and signs of heart failure were carefully evaluated. Follow-up echocardiography was arranged based on the discretion of the care physician. The functional class at enrollment and past history were obtained from the medical records. The study adhered to the Declaration of Helsinki and received approval from the Human Research and Ethics Committee of National Cheng Kung University Hospital (A-ER-102-322).

Echocardiography {#sec2-2}
----------------

Standard transthoracic echocardiography was performed (Vivid 7; GE-VingMed, Horten, Norway) using a 3.5-MHz multiphase array probe in individuals respiring quietly at a left lateral decubitus position. Chamber dimension and wall thickness were measured by the 2D-guided M-mode method, and LVEF was measured by the 2D biplane method of discs \[[@ref16]\]. Left ventricular (LV) mass was obtained by the M-mode-derived linear measurements based on modeling of the left ventricle as a prolate ellipse and indexed by the body surface area. The Doppler sample volume was placed at the tips of the mitral leaflets to obtain the LV inflow blood flow velocity waveforms on the apical four-chamber view. Pulse wave tissue Doppler imaging was obtained from the septal and lateral annulus from the apical four-chamber view, from which average value of early diastolic annulus velocity (*e*') was derived. LV apical four-chamber, two-chamber, and long-axis views for consecutive three cardiac cycles were acquired at a high frame rate (50--90 frames/s). The mean global LV longitudinal systolic strain (GLS) was measured from three apical views by automated function imaging software, as we had reported in detail previously, with very low intra- and interobserver variability \[[@ref17]\]. The ultrasonic data were analyzed offline using dedicated software EchoPac PC 09 (GE-VingMed).

Sphericity, volumetric, and deformation analyses of left atrium {#sec2-3}
---------------------------------------------------------------

The sphericity of the left atrium was assessed by the LA eccentricity index, with a larger or a smaller value indicating an elongated or a spherical left atrium, respectively \[[@ref18]\]. The LA volume was measured using the 2D biplane area---length method \[[@ref19]\] to obtain the maximal endsystolic LA volume (LAVs) and the minimal end-diastolic LA volume (LAVd). LA total emptying fraction (LAEF) was calculated as \[(LAVs - LAVd)/LAVs\] × 100%. LAVi was derived from LAVs indexed to the body surface area.

The method for LA deformation analysis by STE has been described in detail in our previous studies \[[@ref18]\]. The endo-cardial border of the LA was manually defined using a point-and-click technique. After the region of interest (≥8 mm) was automatically generated, manual editing was done to fit the full thickness of the myocardium. Then, a cine loop preview was used to confirm the appropriateness of the region of interest throughout the cardiac cycle. By dividing the LA wall into eight segments (basal septal, middle septal, basal lateral, and middle lateral segments on a 4-chamber view; basal inferior, middle inferior, basal anterior, and middle anterior segments on a 2-chamber view), we recorded the peak value from the time---strain and time---strain rate plots for each individual segment (QRS-timed analysis according to the electrocardiogram). The average value from eight segments were used for analysis (LA~ε~R and LASR~R~; [Figure 2](#F2){ref-type="fig"}). The measurements were repeated three times for each individual, and the average was used for analysis.

![Left atrial strain curve derived from speckle-tracking echocardiographyd--the peak reservoir strain (LAε~R~) can be obtained from both apical four-chamber and apical two-chamber views. The white arrows indicate LAε~R~ of the (A) basal septal and (B) basal inferior walls. LAε~R~ = left atrial reservoir strain.](JMU-25-16-g002){#F2}

Reproducibility {#sec2-4}
---------------

Two independent investigators performed the analysis. Twenty patients were randomly selected for the evaluation of the interobserver variability of LA~ε~R and LASR~R~ measurements by two independent observers. As for intra-observer variability, the same measurements were repeated 1 week apart. The mean percentage error was calculated as the absolute difference divided by the average of the two observations.

Statistical analysis {#sec2-5}
--------------------

All data were presented as mean ± standard deviation unless otherwise stated.

Using the independent *t* test for categorical variables and Pearson's correlation coefficients for continuous variables, we identified factors correlated with a poor LA reservoir function (decreased LA~R~ and LASR~R~) and the interval change of LASR~R~ **(Δ** LASR~R~ = follow-up LASR~R~ - baseline LASR~R~; a minus value indicated declined LA reservoir function). Multiple linear regression analysis was performed to identify the determinants of LA~ε~R or LASR~R~.

The median value of ALAVi (follow-up LAVi - baseline LAVi) was used to stratify patients into groups with or without accelerated LA remodeling. Using the chi-square (χ^2^) test for categorical variables and independent-sample *t* test for continuous variables, we identified factors (*p* \< 0.05) related to accelerated LA remodeling. Then, we conducted multivariate logistic regression analysis by adjusting for significant \[age, E/e', pulmonary arterial systolic pressure (PASP), and ALASR~R~\] and important factors (AF, LVEF, and LAVi). A *p* value \< 0.05 was considered to be statistically significant. All analyses were performed with SPSS 18.0 for Windows (SPSS Institute, Chicago, IL, USA).

Results {#sec1-3}
=======

A total of 159 patients (mean age 57.2 ± 15.7 years, 68% men) with Carpentier II severe MR formed our study group ([Figure 1](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). All of them were asymptomatic (NYHAI) or mildly symptomatic (NYHA II) who refused operation. Among them, 55 patients (mean age 56.2 ± 15.8 years, 57% men) underwent a second nonpostoperative follow-up echocardiography with the same vendor at a mean period of 15.3 ± 8.3 months (interquartile range 8---20 months), from which analysis for LA remodeling was performed. This subgroup *(n* = 55) and the remainder of the patients (n = 104) were alike with regard to clinical characteristics, chamber dimension, LAEF, LVEF, LAVi, LV mass index, LV GLS, and the severity of MR. By comparison of the baseline and follow-up echocardiography, severe MR rendered a progressively enlarged left atrium represented by increased LAVi(48.6 ± 33.1 mL/m^2^ vs. 64.8 ± 67.1 mL/m^2^, **p* \<* 0.001).

###### 

Baseline characteristics of 159 patients.

  Variable                       
  ------------------------------ -------------
  Age (y)                        57.3 ± 15.7
  Men                            108 (68)
  Heart rate (beats/min)         75.1 ± 14.3
  Hypertension                   93 (58)
  Diabetes mellitus              17 (11)
  Atrial fibrillation            25 (16)
  Coronary artery disease        10 (6)
  Smoking                        21 (13)
  Hyperlipidemia                 58 (36)
  LVEDD (cm)                     5.7 ± 0.6
  LVESD (cm)                     3.3 ± 0.6
  LVESDi (cm/m^2^)               1.9 ± 0.4
  LVMi (g/m^2^)                  115.7 ±31.0
  LVEF (%)                       72.7 ±6.7
  LV GLS (%)                     -20.4 ±4.7
  *E/e*′                         12.1 ±4.0
  LAVi (mL/m^2^)                 48.6 ±33.1
  LAEi                           1.2 ± 0.2
  LAEF (%)                       44.6 ± 14.7
  LAε~R~ (%)                     27.5 ± 10.4
  LASR~R~ (1/s)                  2.25 ±0.64
  PASP (mmHg)                    37.2 ±19.0
  EROA (cm^2^)                   0.92 ±0.6
  Regurgitant fraction (%)       58.1 ± 17.8
  Regurgitant volume (mL/beat)   125.9 ±66.0

Data are expressed as mean ± SD or *n* (%).

*E/e*′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LAEF = left atrial ejection fraction; LAEi - = left atrial eccentricity index; LAVi = left atrial volume index; LAɛ~R~ = left atrial reservoir strain; LASR~R~ = left atrial reservoir strain rate; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic dimension; LVESDi = left ventricular endsystolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; PASP = pulmonary arterial systolic pressure; SD = standard deviation.

Determinants of impaired LA reservoir function {#sec2-6}
----------------------------------------------

Correlates for impaired LA reservoir function (denoted by both LA~ε~R and LASR~R~) are the presence of AF, hypertension, older age, elevated *E/e^'^*, LV mass index, LAVi, pulmonary pressure, decreased GLS and LAEF, as well as more elongated left atrium ([Table 2](#T2){ref-type="table"}). Patients with NYHA I without diabetes mellitus had better LA~ε~R but not LASR~R~ ([Table 2](#T2){ref-type="table"}). After multivariate regression analysis, independent factors for impaired baseline LA~ε~R and LASR~R~ are older age, elongated left atrium, and declined LAEF (Table S1). In addition, depressed GLS and increased LAVi were related to a diminished LASR~R~.

###### 

Correlates for decreased left atrial reservoir function.

                                          LA ɛ~R~               LASR~R~
  ----------------------- --------------- --------------------- --------------------
  Continuous variables                    Pearson correlation   coefficient (*r*)
   Age                                    −0.507^\*\*^          −0.392^\*\*^
   Heart rate                             −0.146                −0.090
   LVESDi                                 -0.018                −0.007
   LVEF                                   0.019                 0.071
   LV GLS                                 −0.379^\*\*^          −0.462^\*\*^
   LVMi                                   −0.285^\*\*^          −0.394^\*\*^
   E/*e*′                                 −0.373^\*\*^          −0.235^\*\*^
   LAEi                                   −0.292^\*\*^          −0.257^\*\*^
   LAEF                                   0.514^\*\*^           0.602^\*\*^
   LAVi                                   −0.287^\*\*^          −0.463^\*\*^
   PASP                                   −0.341^\*\*^          −0.319^\*\*^
   EROA                                   −0.071                −0.091
   Regurgitant volume                     −0.118                −0.190
   Regurgitant fraction                   0.107                 0.042
  Categorical variables                                         
   Atrial fibrillation    yes             19.7 ± 10.3^\*\*\*^   1.68 ± 0.6^\*\*\*^
                          No              28.9 ± 9.8            2.35 ± 0.6
   NYHA                                                         
                          I (*n* = 71)    29.5 ± 10.6^\*^       2.26 ± 0.6
                          II (*n* = 88)   25.9 ±10.1            2.24 ± 0.7
   Diabetes               Yes             21.2 ± 7.7^\*\*^      1.97 ± 0.5
    Mellitus              No              28.4 ± 10.5           2.30 ± 0.6
   Hypertension           Yes             24.8 ± 9.2^\*\*\*^    2.11 ± 0.6^\*\*^
                          No              31.2 ± 11.0           2.44 ± 0.7

\* *p* \< 0.05.

\*\* *p* \< 0.01.

\*\*\* *p* \< 0.001.

*E/e*′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LAEF= left atrial ejection fraction; LAEi - = left atrial eccentricity index; LAVi = left atrial volume index; LA ɛ~R~= left atrial reservoir strain; LVEF = left ventricular ejection fraction; LVESDi = left ventricular end-systolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; NYHA = New York Heart Association functional classification; PASP = pulmonary arterial systolic pressure.

Differences between patients with or without accelerated LA remodeling {#sec2-7}
----------------------------------------------------------------------

The clinical characteristics did not differ significantly between the patients with or without accelerated LA remodeling (ΔLAVi ≥ median value) except for age ([Table 3](#T3){ref-type="table"}). As for the echocardiographic parameters, elevated PASP, *E/e^'^*, and negative Δ LASR~R~ (implying a deteriorated LASR~R~ during follow-up) were associated with more rapid LA remodeling. After multivariate logistic regression analysis controlling age, status of AF, LVEF, LAVi, *E/e*', and PASP, only ΔLASR~r~ (odds ratio 0.037, 95% confidence interval 0.003---0.496, *p =* 0.013) exhibited a strong correlation with accelerated LA remodeling ([Table 4](#T4){ref-type="table"}).

###### 

Clinical and echocardiographic parameters between patients with or without accelerated LA remodeling.

                                 Available follow-up echo *N* = 55   Rapid LA remodeling *N* = 27   Slower LA remodeling *N* = 28
  ------------------------------ ----------------------------------- ------------------------------ -------------------------------
  Age (y)                        56.2 ± 15.8                         60.6 ± 17.3^\*^                51.2 ± 12.3
  Men                            34 (57)                             14 (52)                        19 (68)
  Hypertension                   34 (57)                             14 (52)                        18 (64)
  Diabetes mellitus              6 (12)                              2 (7)                          3 (11)
  Atrial fibrillation            6 (10)                              5 (19)^\*^                     1 (4)
  Coronary artery disease        4 (7)                               2 (7)                          2 (7)
  Hyperlipidemia                 26 (43)                             10 (37)                        15 (54)
  NYHA I                         31 (52)                             11 (41)                        14 (50)
  Heart rate (beats/min)         73.6 ± 9.6                          71.6 ± 10.9                    75.4 ± 7.4
  LVEDD (mm)                     5.8 ± 0.7                           5.7 ± 0.                       5.8 ± 0.5
  LVESD (mm)                     3.4 ± 0.6                           3.2 ± 0.5                      3.4 ± 0.5
  LVESDi (mL/m^2^)               2.0 ± 0.3                           1.9 ± 0.3                      1.9 ± 0.3
  LVEF (%)                       72.7 ± 7.4                          74.1 ± 8.3                     71.4 ± 6.6
  LV GLS (%)                     −20.6 ± 4.2                         −20.4 ± 5.0                    −20.7 ± 3.5
  LVMi (g/m^2^)                  114.3 ± 32.5                        121.3 ± 39.3                   106.2 ± 22.8
  E/e′                           12.0 ± 4.2                          13.4 ± 4.5^\*^                 10.6 ± 3.1
  LAVi (mL/m^2^)                 49.5 ± 46.6                         58.2 ± 63.5                    40.7 ± 15.5
  LAEi                           1.2 ± 0.1                           1.24 ± 0.15                    1.16 ± 0.13
  LAEF (%)                       45.5 ± 15.5                         41.5 ± 17.4                    49.4 ± 11.1
  LA ɛ~R~ (%)                    29.1 ± 9.6                          26.4 ± 11.0                    31.2 ± 7.7
  LASR~R~ (1/s)                  2.39 ± 0.55                         2.30 ± 0.66                    2.40 ± 0.41
  ΔLA′Rɛ~R~ (%)                  −0.88 ± 8.4                         −1.41 ± 7.78                   −1.35 ± 9.03
  ΔLASR~R~ (1/s)                 −0.15 ± 0.62                        −0.41 ± 0.45^\*^               0.14 ± 0.59
  PASP (mmHg)                    32.6 ± 16.0                         38.0 ± 18.0^\*^                26.3 ± 10.1
  EROA (cm^2^)                   0.89 ± 0.4                          0.74 ± 0.39                    0.97 ± 0.49
  Regurgitant fraction (%)       56.9 ± 16.5                         53.7 ± 17.3                    59.8 ± 14.9
  Regurgitant volume (mL/beat)   121.3 ± 62.4                        110.2 ± 52.9                   126.1 ± 75.1

The symbol Δ represents the change between baseline and follow-up echocardiography (follow-up minus baseline parameters)^\*^ *p* \< 0.05 between those with and without accelerated LA remodeling.

*E/e*′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LA = left atrial; LAEF = left atrial ejection fraction; LAEi = left atrial eccentricity index; LAVi = left atrial volume index; LA ɛR = left atrial reservoir strain; LASR~R~ = left atrial reservoir strain rate; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic dimension; LVESDi = left ventricular end-systolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; NYHA = New York Heart Association functional classification; PASP = pulmonary arterial systolic pressure.

###### 

Multivariate logistic regression analysis for determinants of accelerated left atrial remodeling.

                        OR (95% CI)            *p*
  --------------------- ---------------------- -------
  Age (y)               0.985 (0.916e1−058)    0.671
  Atrial fibrillation   7.079 (0.514e97−471)   0.144
  *E/e*′                1.001 (0.771e1−300)    0.995
  PASP (mmHg)           1.088 (0.989e1−196)    0.082
  LVEF(%)               1.082(0.955e1−225)     0.216
  LAVi (mL/m^2^)        1.007 (0.978e1−037)    0.627
  ΔLAS~R~ (1/s)         0.037 (0.003e0−496)    0.013

The symbol Δ represents the change between baseline and follow-up echocardiography (follow-up minus baseline parameters).

CI = confidence interval; *E/e*′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; LAVi = left atrial volume index; LASR~R~ = left atrial reservoir strain rate; LVEF = left ventricular ejection fraction; OR = odds ratio; PASP = pulmonary arterial systolic pressure.

Determinants of worse LASR~R~ during follow-up {#sec2-8}
----------------------------------------------

Table S2 shows factors that were related to hastened LASR~R~ deterioration during the follow-up period. Patients with a lower baseline LASR~R~ *(r=* -0.424; *p=* 0.002) were more vulnerable to such aggravation.

The intra- and interobserver mean percentage errors for LA~ε~R were 2.02% and 7.9%, respectively. As for LASR~R~, the intra- and inter-observer mean percentage errors were 2.0% and 2.4%, respectively.

Discussion {#sec1-4}
==========

In chronic severe primary MR, we demonstrated that older age, declined LAEF, depressed GLS, elongated left atrium, and increased LAVi, are independent factors for a diminished LASR~R~. A lower baseline LASR~R~ leads to its faster reduction and is able to predict accelerated LA remodeling.

LA reservoir function and its determinants in severe MR {#sec2-9}
-------------------------------------------------------

Using 2D STE LA deformation analysis, we are able to evaluate LA phasic function (reservoir, conduit, and active contractile functions). The reservoir indexes (LA~ε~R and LASR~R~) are most commonly utilized \[[@ref14][@ref20]\]. In severe primary MR, reservoir function has prognostication in the occurrence of heart failure, paroxysmal AF, and postoperative outcomes (survival, LA reverse remodeling, and postoperative AF) \[[@ref11][@ref12][@ref13][@ref14][@ref21][@ref22][@ref23][@ref24][@ref25]\]. LA reservoir function reflects atrial resilience and elasticity, and is influenced by the loading condition and longitudinal function of the left ventricle. Therefore, it is not surprising that reservoir parameters closely link to other LA parameters (LAEF and LAVi) and LV GLS. Interestingly, we showed that an elongated left atrium is related to a lower reservoir function, while Maiello et al \[[@ref18]\] showed that a spherical left atrium is associated with a poor outcome (higher risk of AF). More studies are needed before drawing a definitive conclusion regarding the impact of LA sphericity in severe MR.

LA remodeling in severe MR {#sec2-10}
--------------------------

In the present study, patients may be in a relatively early stage of severe MR (average LAVi \<60 mL/m^2^). Their left atrium enlarged as MR proceeded. This phenomenon is a compensatory response and may indicate a poor outcome in severe MR. LAVi is a known predictor of mortality, cardiac events, as well as postoperative LA reverse remodeling \[[@ref2][@ref26][@ref27]\]. It is utilized to guide surgical timing to improve life expectancy and outcomes \[[@ref2]\]. Consequently, it is important to recognize contributors for accelerated LA remodeling. We showed that rapid LA remodeling is associated with high pulmonary pressure and *E/e^'^*, suggesting its general link to volume overload in MR \[[@ref2]\]. However, only the reduction of reservoir function (a negative Δ LASR~R~) closely links to rapid LA remodeling in the follow-up period. An LASR~R~ may, therefore, serve as an early marker to identify patients at risk of rapid LA enlargement.

Influence of LA reservoir function on accelerated LA remodeling {#sec2-11}
---------------------------------------------------------------

Our findings suggest that in severe primary MR, LA reservoir function forecasts a rapid expansion of the left atrium, while baseline LAVi and other currently used parameters (age, AF, LVEF, GLS, and PASP) do not. Histologically, impaired LA deformation in severe MR is associated with atrial interstitial fibrosis, resulting in impaired LA elastance and compliance \[[@ref24]\]. Hence, it is likely that patients with poor reservoir deformation are prone to having accelerated LA remodeling. This early and subtle ultrastructural and histological LA change could be best detected by a sensitive tool such as deformation analysis, but not by volumetric and sphericity parameters. To the best of our knowledge, this is the first report of this interesting finding.

Clinical implications {#sec2-12}
---------------------

The current study shows a close relationship between baseline LA reservoir function and future accelerated LA remodeling in chronic severe primary MR. In asymptomatic or mildly symptomatic patients choosing a wait-and-see strategy, LA reservoir deformation analysis may provide additional information for physicians to determine optimal surgical timing. Factors contributing to a poor baseline reservoir function may also serve as warning signs and could be considered in the follow-up assessment of chronic severe MR. To extend the generalizability, future outcome studies incorporating LA reservoir indexes in conjunction with existing markers in asymptomatic severe primary MR are of interest.

Study limitations {#sec2-13}
-----------------

This is a single-center study with a relatively small case number. We included patients with mild symptoms (NYHA II) and AF; however, this population is closer to the real-world circumstances. In addition, functional classification and AF status showed no significance in the analysis. Besides, we used only LA reservoir indexes, and disregarded conduit and contractile parameters. Second, the exact duration of MR was not known due to difficulties in verifying true exposure. However, in patients with or without rapid LA remodeling, there were no significant differences regarding parameters for MR severity as well as LA and LV size. It may imply a comparable duration of severe MR. Large multicenter studies are needed to confirm our results in severe primary MR.

Conclusion {#sec1-5}
==========

Among patients with severe chronic Carpentier II MR and preserved LVEF, an attenuated LASR~R~ during follow-up is associated with accelerated LA remodeling. Patients with a poor baseline LASR~R~ are more vulnerable to its future deterioration.

Appendix A. Supplementary data {#sec1-6}
==============================

Supplementary data related to this article can be found at <http://dx.doi.org/10.1016/j.jmu.2016.09.003>.
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